2m 2m 2m 2m 2m 2m 2m
PRIME MEDICINE (PRME)
NASDAQ
$3.79-$0.02 (-0.55%)
Price as of Oct 22, 2026 7:55 PM EDT- $691.0MMarket Cap
- -25.44%1-Year Change
- BiotechnologyIndustry
PRIME MEDICINE (PRME)
$3.79-$0.02 (-0.55%)
PRME | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.81 | ||
Change | -$0.11 (-2.81%) | ||
Open | $3.92 | ||
High | $4.00 | ||
Low | $3.79 | ||
Previous Close | $3.92 | ||
Volume | 2,438,712 | ||
30-Day Average Volume | 4,877,991 | ||
1-Week Change | 21.73% | ||
1-Month Change | 19.44% | ||
1-Year Change | -25.44% | ||
3-Year Change | -46.64% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 181.4M | ||
Total Assets | $249.0M | ||
Market Cap | $691.0M | ||
Enterprise Value | $643.6M | ||
Period: QTR TTM FY | |||
Revenue | $1.2M | ||
Net Income | -$42.1M | ||
Free Cash Flow | -$41.1M | ||
EBIT | -$42.1M | ||
EBITDA | -$40.3M | ||
Net Working Capital | $65.1M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 558 | ||
P/B | 17 | ||
P/E | -16 | ||
PEG | -1 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 09/10/2019 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue